Skip to main content

Table 2 Body mass index (BMI) and outcomes in diabetics and non-diabetics

From: Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61

 

BMI < 25

BMI 25–29.9

BMI > 30

p value

MACE (1 year)

 Diabetics

21/91 (23.1%)

16/178 (9.0%)

16/135 (14.1%)

0.001

 Non diabetics

36/550 (6.6%)

44/744 (5.9%)

15/306 (4.9%)

0.621

Death (1 year)

 Diabetics

13/91 (14.3%)

9/178 (5.1%)

9/135 (6.7%)

0.023

 Non-diabetics

21/550 (3.8%)

17/744 (2.3%)

4/306 (1.3%)

0.065

Revascularization (1 year)

 Diabetics

13/91 (14.3%)

11/178 (6.2%)

7/135 (5.2%)

0.025

 Non-diabetics

26/550 (4.7%)

53/744 (7.1%)

15/306 (4.9%)

0.14

Stroke (1 year)

 Diabetics

1/91 (1.1%)

5/178 (2.8%)

3/135 (2.2%)

0.667

 Non-diabetics

5/550 (0.9%)

5/744 (0.7%)

3/306 (1.0%)

0.838